Gregory Bailey bought $3.0M of BHVN
director at Biohaven Ltd.. 400,000 shares at an average of $7.50, traded Nov 13, 2025, filed Nov 17, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.0M at market
- +6Relative to holdingsHoldings up 25%
- +18Price context4% above the 52-week low; 84% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +31.4%, 3m +37.4%, 6m +2.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001935979-25-000096, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | POpen-market purchase Common Shares | +400,000 | $7.50 | $3.0M | 2,020,071 | Nov 17, 2025 |
Related signals
Other insiders at Biohaven Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 61Notable | BHVNbuy Biohaven Ltd. | John W Childs director | $864k 28,400 shares | +1% | |
| 69Notable | Biohaven Ltd. | George C. Clark VP, Chief Accounting Officer | $145k 17,000 shares | +567% | |
| 83Strong | Biohaven Ltd. | John W Childs director | $25M 3,333,333 shares | +144% | |
| 93Strong | Biohaven Ltd. | Vlad Coric Chief Executive Officer | $5.0M 666,666 shares | +77% | |
| 63Notable | BHVNbuy Biohaven Ltd. | John W Childs director | $996k 32,700 shares | +1% | |
| 40Moderate | BHVNbuy Biohaven Ltd. | John W Childs director | $1.0M 29,000 shares | +1% | |
| 26Weak | BHVNbuy Biohaven Ltd. | Gregory Bailey director | $221k 5,000 shares | +0% | |
| 63Notable | BHVNbuy Biohaven Ltd. | John W Childs director | $1.0M 28,400 shares | +1% | |
| 56Moderate | BHVNbuy Biohaven Ltd. | Bruce Car Chief Scientific Officer | $1.0M 30,000 shares | - | |
| 63Notable | BHVNbuy Biohaven Ltd. | John W Childs director | $996k 28,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.